Anne Therese Aesthetic Medicine, a physician-supervised practice with locations in Lewis Center, Gahanna, Cape Coral, and Bonita Springs, has detailed the clinical approach that distinguishes subtle refinement from aesthetic excess in injectable treatments. The practice emphasizes that the overfilled appearance, a common patient concern, is not an unavoidable consequence of dermal fillers or neuromodulators. Instead, it results from decisions made around volume calibration, product selection, and anatomical placement.
According to the practice, natural-looking injectable results depend on matching volume, product properties, and placement to the patient's facial anatomy. Overfilled outcomes typically occur when too much product is placed within a single session, when the selected filler's physical properties are mismatched to the treatment area, or when filler is added without accounting for the balance between facial compartments. For neuromodulators like Botox, overshoot follows a different mechanism. Neuromodulators function by blocking the nerve signal that causes targeted muscles to contract. When the dose is too high, or when injection sites do not account for the patient's expressive muscle anatomy, the result can be restricted movement rather than softened dynamic lines. The clinical goal is preserved expression with reduced line depth, not immobilized facial movement.
The practice underscores the importance of product selection and facial proportion. Hyaluronic acid fillers vary in physical properties, and product selection is a defined part of the clinical plan. For instance, fillers designed for structural support in deeper tissue planes, such as Juvederm Voluma XC for mid-face volume, carry different rheological properties than those formulated for superficial refinement, such as Juvederm Volbella XC, which is commonly used for lip border definition. Placing a high-resistance filler in an area that requires soft, natural movement can produce visible rigidity. The licensed providers at Anne Therese Aesthetic Medicine select products based on the anatomical zone, the depth of placement, and the patient's existing tissue composition. Volume calibration follows the same principle: adding filler to one area without accounting for adjacent compartments can shift proportions in ways the patient did not anticipate. The practice applies incremental refinement rather than maximum volume within a single session.
The consultation is the clinical starting point for natural-looking results. Providers review facial anatomy, treatment history, and patient goals before recommending any product or dose. For patients who have not previously had injectables, the consultation includes an explanation of how each treatment works, what realistic outcomes look like at different volume levels, and what the follow-up process involves. Anne Therese Aesthetic Medicine applies a conservative starting point as a clinical standard. Providers begin at lower doses and assess results at the appropriate follow-up interval before introducing additional product: 10 to 14 days for Botox, and two to four weeks for dermal fillers. This approach allows patients to observe how their anatomy responds and make informed decisions about further refinement, rather than discovering that excess product was placed during a single appointment.
The practice encourages patients seeking natural-looking injectable results to schedule a consultation at one of their four locations. This approach is part of a broader trend in aesthetic medicine toward more nuanced and individualized treatment planning, which can reduce the risk of unsatisfactory outcomes and enhance patient satisfaction.
